CME Sponsor: 

International Medical Press


Location:
This is a web-based enduring material CME

Course Directors/Instructors:
Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director, Joslin Diabetes Center
Boston, MA

William Polonsky, PhD, CDE
Associate Clinical Professor
University of California, San Diego
President, Behavioral Diabetes Institute
San Diego, CA

Registration Fees: Free

Number of Credits:
1.5 AMA PRA Category 1 Credit(s)TM
1.5 contact hours (0.15 CEUs)

Link

Detailed Description:

The prevalence of type 2 diabetes is increasing at an alarming rate, and timely treatment is needed to prevent or delay the devastating complications of this disease. Since type 2 diabetes is characterized by progressive ?-cell failure, earlier and more aggressive use of insulin therapy is often required to help patients meet their glycemic targets. As healthcare professionals (HCPs) face the growing number of patients who require more specialized and complex care, they will need practical strategies for managing complex patients.

The goal of this online activity is to reinforce the need for a team approach between HCPs and patients with type 2 diabetes to achieve tight glycemic control on insulin therapy. This online activity is based upon content originally presented at a symposium held on June 7, 2008, in San Francisco, California.

Learning Objectives:
  • Select appropriate insulin therapy for patients unable to achieve adequate glycemic control on oral agent therapy
  • Explain how to advance insulin therapy if intensification is required
  • Describe strategies to address challenges patients may face with initiation or intensification of insulin therapy